Factors Affecting the Postoperative Outcome in Adult Cardiac Surgery with Cardiopulmonary Bypass |
Lee, Sung-Chul
(Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan)
Kim, Yun-Tae (Seoul Medical Science Institute (SMSI)) Moon, Seong-Min (Department of Biomedical Laboratory of Science, College of Smart Foods and Drugs, Inje University) Hyun, Kyung-Yae (Department of Biomedical Laboratory of Science, College of Smart Foods and Drugs, Inje University) Kim, Dae-Sik (Department of Clinical Laboratory Science, Dongnam health college) Choi, Seok-Cheol (Seoul Medical Science Institute (SMSI)) |
1 | Hammerschmidt, D. E., D. F. Stroneck and T. K. Bowers. 1981. Complement activation and neutropenea occuring during cardiopulmonary bypas. J. Thorac. Cardiovasc. Surg. 81. 370-377. |
2 | Georgiadis, D., A. Berger and E. Kowatschem. 2000. Predictive value of s-100 and neuron-specific enolase serum levels for adverse neurologic outcome after cardiacsurgery. J. Thorac. Cardiovasc. Surg. 119, 138-147. DOI ScienceOn |
3 | Hiramatsu, T., Y. Imai and I. Takanashi. 1997. Time course of endothelin-1 and nitrate anion levels after cardiopulmonary bypass in congenital heart defects. Ann. Thorac. Surg. 63, 648-652. DOI ScienceOn |
4 | Johnson, P., C. Lundqvist, A. Lindrgren, I. Ferencz, C. Alling and E. Stahl. 1995. Cerebral complications after cardiac surgery assessed by S-100 and NSE levels in blood. J. Cardiovsc. Anesth. 9, 694-699. DOI ScienceOn |
5 | Immer, F. F., F. Stocker and A. M. Seiler. 1998. Comparison of troponin-I and troponin-T after pediatric cardiovascular surgery. Ann. Thorac. Surg. 66, 2073-2077. DOI ScienceOn |
6 | Hynyen, M., O. Saijonmaa, I. Tickkanen, J. Heinonen and F. Fyhrquist. 1992. Increased plasma endothelin immunoreactivity during cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 103, 1024-1034. |
7 | Hirsch, R., C. L. Dent and M. K. Wood. 1998. Patterns and potential value of cardiac troponin I elevations after pediatric cardiac operations. Ann. Thorac. Surg. 65, 1394-1399. DOI ScienceOn |
8 | Komai, H., I. T. Adatia, M. J. Elliott, M. R. de Leval and S. G. Hawrth. 1993. Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease. J. Thorac. Cardiovasc. Surg. 106, 473-478. |
9 | Kishimoto, T. 1989. The biology of interleukin-6. Blood 74, 1-10. |
10 | Taggart, D. P., L. Hajinikolas and J. Hooper. 1997. Effects of age and ischemic times on biochemical evidence of myocardial injury after pediatric cardiac operations. J. Thorac. Cardiovasc. Surg. 113, 728-735. DOI ScienceOn |
11 | Chenoweth, D. E., S. W. Cooper and T. E. Hugli. 1981. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N. Engl. J. Med. 304, 497-503. DOI ScienceOn |
12 | Gao, F., F. Harris and S. Sapsed-Byrne. 1999. Time course of neurone-specific enolase and S-100 protein release during and after coronary artery bypass grafting. Br. J. Anaesth. 82, 266-267. DOI ScienceOn |
13 | Francis, A., A. J. Rivett and J. A. Roth. 1983. Activity of neuron-specific enolase in normal and lesioned rat brain. Brain Res. 263, 89-95. DOI ScienceOn |
14 | Schmechel, D., P. J. Marangos, A. P. ZisP, M. Brightman and F. K. Goodwin. 1987. Brain enolase as specific markers of neuronal and glial cells. Science 199, 313-315. DOI ScienceOn |
15 | Hans, P., V. Bonhomme, J. Collette and G. Moonen. 1993. Neuron-specific enolase as a marker of in vitro neuronal damage, part I: assessment of neuronspecific enolase as a puantitative and specific marker of neuronal damage. J. Neurosurg. Anesthesiol. 5, 111-116. DOI |
16 | Marangos, P. J., D. Schmechel, A. M. Parma, R. L. Clark and F. K. Goodwin. 1979. Measurement of neuron-specific (NSE) and non-neuronal (NNE) isoenzymes of enolase in rat. monkey and human nervous tissue. J. Neurochem. 33, 319-329. DOI |
17 | Yoshibayashi, M. and K. Nishioka. 1991. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Circulation 84, 2280-2285. DOI ScienceOn |
18 | Yanagisawa, M., H. Kasaki, Y. Tomobe, M. Kobayshin, Y. Mitsui, Y. Yazaki, K. Goto K and T. Masaki. 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411-415. DOI ScienceOn |
19 | Luscher, T. F. 1992. Endothelin: systemic arterial and pulmonary effects of a new peptide with potent biologic propeties. Am. Rev. Respir. Dis. 146, S56-S60. DOI |
20 | Steinberg, R., C. Gueniau, H. Scarna, A. Keller, M. Worcel and J. F. Pujol. 1984. Experimental brain ischemia: neuron-specific enolase level in cerebrospinal fluid as an index of neuronal damage. J. Neurochem. 43, 19-24. DOI |
21 | Kirklin, J. K., S. Westaby and E. H. Blackstone. 1983. Complement and damaging effects of cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 86, 845-847. |
22 | Kongsgaard, U. E., N. Smith-Erichsen and O. Geiran. 1989. Different activation patterns in the plasma kallikrein-kinin and complement ststems during coronary bypass surgery. Acta. Anaesthesiol. Scand. 33, 343-347. DOI ScienceOn |
23 | Marangos, P. J and D. E. Schmechel. 1987. Neuron specific enolase, a clinically useful marker for neurons and neuronendocrine cells. Annu. Rev. Neurosci. 10, 269-295 DOI ScienceOn |